Number of shares outstanding for Amicus Therapeutics (FOLD)

Number of shares outstanding as of December 2025 : 308,468,423

According to Amicus Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 308,468,423. At the end of 2025 the company had 308,468,423 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Amicus Therapeutics from 2005 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	0.30 B	1.24%
2024	0.30 B	3.02%
2023	0.29 B	2.26%
2022	0.28 B	8.14%
2021	0.26 B	3.2%
2020	0.25 B	1.76%
2019	0.25 B	34.63%
2018	0.18 B	17.64%
2017	0.16 B	14.32%
2016	0.14 B	18.47%
2015	0.11 B	36.54%
2014	86.95 M	75.23%
2013	49.62 M	0.29%
2012	49.47 M	41.45%
2011	34.97 M	26.62%
2010	27.62 M	22.12%
2009	22.62 M	0.46%
2008	22.51 M	1.01%
2007	22.29 M	2928.92%
2006	0.73 M	79.41%
2005	0.41 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Biogen BIIB	146,600,000	-52.47%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	192,032,000	-37.75%	🇺🇸 USA
Esperion Therapeutics ESPR	200,736,136	-34.92%	🇺🇸 USA
GlaxoSmithKline GSK	2,017,000,000	553.88%	🇬🇧 UK
Lexicon Pharmaceuticals LXRX	363,399,000	17.81%	🇺🇸 USA
Novo Nordisk NVO	4,443,500,000	1,340.50%	🇩🇰 Denmark

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions